PEGASUS by 1910 — Product Research | aVenture

PEGASUS is a state-of-the-art multimodal AI model that engineers novel drug-like macrocyclic peptides. It combines predictive and generative modules trained on 1910's proprietary Permeability Proxy Assay, quantum mechanical simulations, and Caco-2/MDCK ground-truth permeability data to balance permeability, aqueous solubility, polarity, and target potency.

The platform supports in silico triage, lead optimization, and de novo peptide design, and can be fine-tuned on partner proprietary data through co-engineering engagements.

PEGASUS - Direct Competitors

Attribute	PEGASUS	Catalyst, Creation	Drug Design Engine
Provider	1910 1910.ai$26.9M disclosed funding · Series A	Lila Sciences lila.ai$550M disclosed funding · Series A	Isomorphic Labs isomorphiclabs.com$2.8B disclosed funding · Series B
Founded	2018	2023	2021
Sells To	Enterprise, Pharmaceutical	Enterprise	Enterprise
Pricing Model	Licensing	—	Licensing
Ownership	Venture-backed	Venture-backed	Venture-backed

PEGASUS

Provider 1910 1910.ai$26.9M disclosed funding · Series A

Founded 2018

Sells To Enterprise, Pharmaceutical

Pricing Model Licensing

Ownership Venture-backed

Catalyst, Creation

Provider Lila Sciences lila.ai$550M disclosed funding · Series A

Founded 2023

Sells To Enterprise

Pricing Model —

Ownership Venture-backed

Drug Design Engine

Provider Isomorphic Labs isomorphiclabs.com$2.8B disclosed funding · Series B

Founded 2021

Sells To Enterprise

Pricing Model Licensing

Ownership Venture-backed

PEGASUS - Similar Products & Services

Pharma.ai Insilico Medicine
Pharma.ai is Insilico Medicine's generative AI platform for drug discovery, target identification, and molecule design.
Recursion OS